Esmolol | List of Frontiers open access articles

Original Research

Published on 30 Sep 2022

The first case series analysis on efficacy of esmolol injection for in-hospital cardiac arrest patients with refractory shockable rhythms in China

in Cardiovascular and Smooth Muscle Pharmacology

Rui Lian
Guochao Zhang
Shengtao Yan
Lichao Sun
Wen Gao
Jianping Yang
Guonan Li
Rihong Huang
Xiaojie Wang
Renyang Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.930245

5,747 views
9 citations

Original Research

Published on 04 Dec 2025

Nutritional support contributes to improving cardiac function and nutritional status in atrial fibrillation patients receiving treatment with esmolol hydrochloride

in Cardiovascular Nursing

Xiaochao Liu
Yulong Fan
Zhi Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1721246

771 views

Study Protocol

Published on 30 Jul 2025

Efficacy and safety of heart rate control with esmolol on the incidence and duration of organ failure in predicted severe acute pancreatitis: protocol of a multicenter, open-label, randomized controlled trial

in Gastroenterology

Mingfeng Huang
Rong Wei
Lu Ke
Weijian Li
Jian Song
Haibin Ni
Xiaofei Huang
Yun Sun
Lu Fu
Yanhua Li

Frontiers in Medicine

doi 10.3389/fmed.2025.1642721

2,992 views
2 citations

Original Research

Published on 23 Aug 2022

Novel topical esmolol hydrochloride improves wound healing in diabetes by inhibiting aldose reductase, generation of advanced glycation end products, and facilitating the migration of fibroblasts

in Diabetes: Molecular Mechanisms

Sudhir A. Kulkarni
Supreet K. Deshpande
Ashu Rastogi

Frontiers in Endocrinology

doi 10.3389/fendo.2022.926129

10,627 views
16 citations

Original Research

Published on 12 May 2025

Esmolol improves sepsis outcomes through cardiovascular and immune modulation

in Inflammation Pharmacology

Da Jing
Li Xiong
Rong Zhang
Hong Fang
Lin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1498227

2,115 views
4 citations

Original Research

Published on 20 Jun 2024

Effect of ultrashort-acting β-blockers on 28-day mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a meta-analysis of randomized controlled trials and trial sequential analysis

in Pharmacoepidemiology

Po Huang
Fusheng Liu
Xiao Hu
Bo Li
Xiaolong Xu
Qingquan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1380175

3,746 views
7 citations

Systematic Review

Published on 01 Jun 2021

The Efficacy and Safety of Esmolol for Septic Shock: A Systematic Review and Meta-analysis of Randomized Controlled Trials

in Drugs Outcomes Research and Policies

Po Huang
Xiangchun Zheng
Zhi Liu
Xiaolei Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.682232

9,227 views
12 citations

Systematic Review

Published on 24 Sep 2024

Association of beta blockers and mortality in adults with septic shock: systematic review and meta-analysis of randomized clinical trial

in Intensive Care Medicine and Anesthesiology

Gustavo Adolfo Vásquez-Tirado
Claudia Vanessa Quispe-Castañeda
Edinson Dante Meregildo-Rodríguez
María Cuadra-Campos
Niler Manuel Segura-Plasencia
Yessenia Katherin Arbayza-Avalos
Hugo Nelson Alva-Guarniz
Wilson Marcial Guzmán-Aguilar
Petterson Zavaleta-Alaya

Frontiers in Medicine

doi 10.3389/fmed.2024.1448573

6,852 views
13 citations

Mini Review

Published on 20 Aug 2021

Crash Landing of Thyroid Storm: A Case Report and Review of the Role of Extra-Corporeal Systems

in Thyroid Endocrinology

Shir Lynn Lim
Kangjie Wang
Pak Ling Lui
Kollengode Ramanathan
Samantha Peiling Yang

Frontiers in Endocrinology

doi 10.3389/fendo.2021.725559

16,644 views
20 citations

Original Research

Published on 02 Dec 2013

Characteristic interactivity of landiolol, an ultra-short-acting highly selective β1-blocker, with biomimetic membranes: Comparisons with β1-selective esmolol and non-selective propranolol and alprenolol

in Experimental Pharmacology and Drug Discovery

Hironori Tsuchiya
Maki Mizogami

Frontiers in Pharmacology

doi 10.3389/fphar.2013.00150

6,973 views
20 citations

Case Report

Published on 14 Jul 2025

Thyroid storm during the recovery phase after non-thyroid surgery in a hyperthyroid patient: a case report and literature review

in Otorhinolaryngology - Head and Neck Surgery

Jiyu Zeng
Ting Yang
Li Wu

Frontiers in Surgery

doi 10.3389/fsurg.2025.1633314

4,014 views

Articles

The first case series analysis on efficacy of esmolol injection for in-hospital cardiac arrest patients with refractory shockable rhythms in China

Nutritional support contributes to improving cardiac function and nutritional status in atrial fibrillation patients receiving treatment with esmolol hydrochloride

Efficacy and safety of heart rate control with esmolol on the incidence and duration of organ failure in predicted severe acute pancreatitis: protocol of a multicenter, open-label, randomized controlled trial

Novel topical esmolol hydrochloride improves wound healing in diabetes by inhibiting aldose reductase, generation of advanced glycation end products, and facilitating the migration of fibroblasts

Esmolol improves sepsis outcomes through cardiovascular and immune modulation

Effect of ultrashort-acting β-blockers on 28-day mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a meta-analysis of randomized controlled trials and trial sequential analysis

The Efficacy and Safety of Esmolol for Septic Shock: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Association of beta blockers and mortality in adults with septic shock: systematic review and meta-analysis of randomized clinical trial

Crash Landing of Thyroid Storm: A Case Report and Review of the Role of Extra-Corporeal Systems

Characteristic interactivity of landiolol, an ultra-short-acting highly selective β1-blocker, with biomimetic membranes: Comparisons with β1-selective esmolol and non-selective propranolol and alprenolol

Thyroid storm during the recovery phase after non-thyroid surgery in a hyperthyroid patient: a case report and literature review